Treatment of chronic hepatitis B
Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes
Differentially expressed cellular genes following HBV
Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants
The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B
Pegylated interferon-alpha 2b–ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis
Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B
Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium
Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis
Liver enzymes elevation after HAART in HIV-HCV co-infection
SEN virus infection in patients with hepatocellular carcinoma
Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan